IB Consultancy is proud to announce that DxTerity Diagnostics confirms as a Silver Sponsor for NCT Asia & SISPAT 2017, taking place from 21-23 March 2017 at the Marina Bay Sands in Singapore. We are looking forward to working with DxTerity Diagnostics!

About DxTerity Diagnostics

DxTerity Diagnostics has developed an innovative molecular test for acute radiation exposure – the REDI-Dx™ RUO* test. Using the DxTerity DxDirect™ method for direct-from-sample, multiplex gene-expression analysis and a proprietary panel of radiation-sensitive biomarkers, REDI-Dx™ is a simple, rapid, highly specific, and low-cost solution for biodosimetry and emergency management research that is superior to existing methods for estimating radiation exposure. REDI-Dx™ RUO measures the expression of a panel of inflammation and immune system biomarkers that respond to radiation in a very predictable and dose-dependent manner.  Interested in learning more? Please visit the DxTerity website.